Icke-organiska tillväxtmöjligheter inom intensivvården för ett medicintekniskt företag
(2008) MIO920Production Management
- Abstract
- The Master Thesis, which is a part of the education to become Master of
Science in Engineering, Industrial Engineering and Management, Faculty of
Engineering, Lund University, has been written at Gambro in Lund. In 2006
new owners bought Gambro and Gambro has been working on new
guidelines and strategies during the past year. The Master Thesis became a
part of the work with new strategies and therefore our work was set to
investigate non-organic growth opportunities within the intensive care for
Gambro.
The issues we had to work with were to identify the structure of the market
for the intensive care and how a market and a company should be valued.
Furthermore we hade to investigate what was affecting the possibilities for
... (More) - The Master Thesis, which is a part of the education to become Master of
Science in Engineering, Industrial Engineering and Management, Faculty of
Engineering, Lund University, has been written at Gambro in Lund. In 2006
new owners bought Gambro and Gambro has been working on new
guidelines and strategies during the past year. The Master Thesis became a
part of the work with new strategies and therefore our work was set to
investigate non-organic growth opportunities within the intensive care for
Gambro.
The issues we had to work with were to identify the structure of the market
for the intensive care and how a market and a company should be valued.
Furthermore we hade to investigate what was affecting the possibilities for
growth, if Gambro should acquire or ally with an interesting company and
how strategies and possible synergies affect the choice of markets and
companies. To get a structural working process we developed a growth
model to use during our work and we would like to recommend Gambro to
use this model in their work with non-organic growth opportunities.
We have investigated six different companies that could be of interest for
Gambro to acquire or ally with, and valued them according to the criteria we
found during our work. Of these six companies it is only one company we
would like to recommend Gambro to further investigate for an acquisition.
Our conclusion is also that Gambro’s department for intensive care should
have the ambition to get a new core competence. From the current core –
dialysis – to a broader term – extra corporeal therapy. Since extra corporeal
treatment can be used in many different areas we think Gambro’s
department for intensive care should offer extra corporeal treatment for all
the vital organs in the body. The vision should be for Gambro to be market
leading within the area of extra corporeal therapy in the intensive care for all
the vital organs. (Less)
Please use this url to cite or link to this publication:
http://lup.lub.lu.se/student-papers/record/1979227
- author
- Andersson, Maria and Olofsson, Sara
- supervisor
- organization
- course
- MIO920
- year
- 2008
- type
- M1 - University Diploma
- subject
- other publication id
- 08/5300
- language
- Swedish
- id
- 1979227
- date added to LUP
- 2011-06-17 12:47:19
- date last changed
- 2011-06-20 11:23:33
@misc{1979227, abstract = {{The Master Thesis, which is a part of the education to become Master of Science in Engineering, Industrial Engineering and Management, Faculty of Engineering, Lund University, has been written at Gambro in Lund. In 2006 new owners bought Gambro and Gambro has been working on new guidelines and strategies during the past year. The Master Thesis became a part of the work with new strategies and therefore our work was set to investigate non-organic growth opportunities within the intensive care for Gambro. The issues we had to work with were to identify the structure of the market for the intensive care and how a market and a company should be valued. Furthermore we hade to investigate what was affecting the possibilities for growth, if Gambro should acquire or ally with an interesting company and how strategies and possible synergies affect the choice of markets and companies. To get a structural working process we developed a growth model to use during our work and we would like to recommend Gambro to use this model in their work with non-organic growth opportunities. We have investigated six different companies that could be of interest for Gambro to acquire or ally with, and valued them according to the criteria we found during our work. Of these six companies it is only one company we would like to recommend Gambro to further investigate for an acquisition. Our conclusion is also that Gambro’s department for intensive care should have the ambition to get a new core competence. From the current core – dialysis – to a broader term – extra corporeal therapy. Since extra corporeal treatment can be used in many different areas we think Gambro’s department for intensive care should offer extra corporeal treatment for all the vital organs in the body. The vision should be for Gambro to be market leading within the area of extra corporeal therapy in the intensive care for all the vital organs.}}, author = {{Andersson, Maria and Olofsson, Sara}}, language = {{swe}}, note = {{Student Paper}}, title = {{Icke-organiska tillväxtmöjligheter inom intensivvården för ett medicintekniskt företag}}, year = {{2008}}, }